Methods: Children between the age of 1 and 8 years scheduled for ophthalmic procedure, were prospectively enrolled from December 2017 to February 2018, and were randomly assigned to two groups based on whether they received oral midazolam (0, 2mg / kg) or oral melatonin (0, 5mg / kg) premedication.